Download PDF
Thromb Haemost 1979; 42(04): 1296-1305
DOI: 10.1055/s-0038-1657025
Original Article
Schattauer GmbH Stuttgart

Spectrophotometric Assays of Prothrombin in Plasma of Patients Using Oral Anticoagulants

R M Bertina
The Hemostasis and Thrombosis Research Unit, Department of Medicine, University Hospital Leiden, Leiden, The Netherlands
,
W van der Marel-van Nieuwkoop
The Hemostasis and Thrombosis Research Unit, Department of Medicine, University Hospital Leiden, Leiden, The Netherlands
,
E A Loeliger
The Hemostasis and Thrombosis Research Unit, Department of Medicine, University Hospital Leiden, Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 06 March 1979

Accepted 01 May 1979

Publication Date:
23 August 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Two spectrophotometric assays for prothrombin have been developed and compared with a one stage coagulant and an immunological assay. One of these assays (called the XAPC assay) uses a combination of factor Xa, phospholipid, Ca2+ and factor V as activator of prothrombin, and measures only normal prothrombin. The second (the ECAR assay) uses Echis carinatus venom as activator. This assay measures both normal prothrombin and PIVKA II (protein induced by vitamin K antagonists/absence). Combination of the results obtained by the XAPC and ECAR assays provides rapid and reliable information on the degree of “subcarboxylation” of prothrombin (oral anticoagulation, vitamin K deficiency).

For patients on long term anticoagulant treatment the prothrombin time (Thrombotest) shows better correlation with the ratio prothrombin/prothrombin plus PIVKA II (XAPC/ ECAR) than with the factor II concentration. For patients starting the anticoagulant treatment there is no correlation between the Thrombotest time and the XAPC/ECAR ratio.

It seems doubtful that (a) spectrophotometric factor II assay(s) will be as useful as the prothrombin time in the control of oral anticoagulation.

 

  • References

  • 1 Axelsson G, Korsan-Bengtsen K, Waldenstrom J. 1976; Prothrombin determination by means of a chromogenic peptide substrate. Thrombosis and Haemostasis 36: 517
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Bell WN, Alton HD. 1954; A brain exstract as a substitute for platelet suspension in the thromboplastin generation test. Nature 174: 880
    CrossrefPubMedGoogle Scholar
  • 3 Bergstrom K, Blomback M. 1974; Determination of plasma prothrombin with a reaction rate analyzer using a synthetic substrate. Thrombosis Research 4: 719
    CrossrefPubMedGoogle Scholar
  • 4 Bergstrom K, Egberg N. 1978; Determination of vitamin K sensitive coagulation factors in plasma. Studies on three methods using synthetic chromogenic substrates Thrombosis Research 12: 531
    CrossrefPubMedGoogle Scholar
  • 5 Franza BR, Aronson DL, Finlayson JS. 1975; Activation of human prothrombin by a procoagulant fraction from the venom of Echis carinatus. Identification of a high molecular weight intermediate with thrombin activity Journal of Biological Chemistry 250: 7057
    PubMedGoogle Scholar
  • 6 Hellemans J, Vorlat M, Verstraete M. 1963; Survival time of prothrombin and factors VII, IX and X after completely synthesis blocking dosis of coumarin derivatives. British Journal of Haematology 9: 506
    CrossrefPubMedGoogle Scholar
  • 7 Kirchhof BR J, Vermeer C, Hemker HC. 1978; The determination of prothrombin using synthetic chromogenic substrates; choice of a suitable activator. Thrombosis Research 13: 219
    CrossrefPubMedGoogle Scholar
  • 8 Kornalik F, Blomback B. 1975; Prothrombin activation induced by Ecarin - a prothrombin converting enzyme from Echis carinatus venom. Thrombosis Research 6: 53
    CrossrefPubMedGoogle Scholar
  • 9 Latallo ZS, Teisseyre E. 1977. Amidolytic assay of prothrombin activated with ecarin, a procoagulant from Echis Carinatus Venom. In WITT I. (ed.) New Methods for the Analysis of Coagulation Using Chromogenic Substrates. Walter de Gruyter; Berlin - New York: p 181
    Google Scholar
  • 10 Owren PA. 1949; A quantitative one-stage method for the assay of prothrombin. Scandinavian Journal of Clinical and Laboratory Investigation 1: 81
    CrossrefPubMedGoogle Scholar
  • 11 Prydz H. 1977; Vitamin K-dependent clotting factors. Seminars in Thrombosis and Hemostasis 4: 1
    PubMedGoogle Scholar
  • 12 Róka L, Koch R, Bleyl H. 1977. Studies on the determination of prothrombin with S2160. In WITT I. (ed.) New Methods for the Analysis of Coagulation Using Chromogenic Substrates. Walter de Gruyter; Berlin - New York: p 171
    Google Scholar
  • 13 Schieck A, Habermann E, Kornalik F. 1972; The prothrombin activating principle from Echis carinatus venom II. Coagulation studies in vitro and in vivo. Naunyn-Schmiedebergs Archives of Pharmacology 274: 1
    PubMedGoogle Scholar
  • 14 Svendsen L, Blomback B, Blomback M, Olsson PI. 1972; Synthetic chromogenic substrates for determination of trypsin, thrombin and thrombin-like enzymes. Thrombosis Research 1: 267
    CrossrefPubMedGoogle Scholar
  • 15 Vermeer C, Govers-Riemslag JW P, Soute BA M, Lindhout MJ, Kop J, Hemker HC. 1978; The role of blood clotting factor V in the conversion of prothrombin and decarboxy prothrombin into thrombin. Biochimica et Biophysica Acta 538: 521
    CrossrefPubMedGoogle Scholar
  • 16 Wuk EM, Van Kahlé LH, Jenkins CS P, Ten Cate JW. 1978. The determination of prothrombin using an automated amidolytic technique. In Abstr. XVII Congress of the International Society of Hematology. Paris: 1978. p 862
    Google Scholar
  • 17 Witt I. 1977. Determination of plasma prothrombin with chromozym TH. In Witt I. (ed.) New Methods for the Analysis of Coagulation Using Chromogenic Substrates. Walter de Gruyter; Berlin - New York: p 155
    Google Scholar